Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(33%)
Results Posted
100%(3 trials)

Phase Distribution

Ph phase_1
1
17%
Ph phase_3
1
17%
Ph not_applicable
1
17%
Ph phase_2
2
33%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 31 (20.0%)
N/A1 (20.0%)

Trials by Status

completed350%
unknown117%
recruiting117%
active_not_recruiting117%

Recent Activity

2 active trials
Showing 5 of 6
completedphase_2

Linezolid Dosing Strategies in Drug-Resistant TB

NCT05007821
recruitingnot_applicable

Linezolid Plus Standard of Care

NCT06958835
active_not_recruitingphase_3

Alternative Antibiotics for Syphilis

NCT05069974
unknown

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT

NCT05944445
completedphase_2

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

NCT03747497
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05007821Phase 2

Linezolid Dosing Strategies in Drug-Resistant TB

Completed
NCT06958835Not Applicable

Linezolid Plus Standard of Care

Recruiting
NCT05069974Phase 3

Alternative Antibiotics for Syphilis

Active Not Recruiting
NCT05944445

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT

Unknown
NCT03747497Phase 2

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

Completed
NCT00795145Phase 1

A Study To Assess The Effect Of Linezolid On QTc Interval

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6